Researchers studied the implementation of a new patient-reported outcome instrument to measure and manage fatigue in patients with systemic lupus erythematosus.
Researchers assessed the attainment of traditional cardiovascular risk factor therapeutic goals in patients with antiphospholipid syndrome vs those with rheumatoid arthritis and diabetes mellitus.
Marcus Säemann, MD, talks about the role of SGLT-2 inhibitors and their strong nephroprotective potential that may benefit patients with ANCA-associated vasculitis and lupus nephritis.
Researchers identified the characteristics and distribution of discoid lupus erythematosus skin lesions among Black vs non-Black patients.
To address disparities in lupus, clinical trials that are racially and ethnically diverse, inclusive, and robust, must be conducted.
Researchers studied the risk factors for progression of carotid intima media thickness and plaque in women with and without systemic lupus erythematosus.
Researchers determined the effect of attaining low disease activity or remission in childhood systemic lupus erythematosus.
Karen Costenbader, MD, provides a roundup of all the exciting and compelling news and research in lupus, as presented at the ACR Convergence 2021.
Current, evidence-based recommendations for the management of cutaneous lupus erythematosus (CLE) in the presence or absence of systemic lupus erythematosus (SLE) in adults, young people, and children are provided.
Researchers determined the link between patient-reported outcome measure scores and organ damage in patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis.
